Stocktoria
SeaStar Medical Holding Corp ICU
Nasdaq · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2021-01-26
SeaStar Medical Holding Corp financials (annual)
Bars are annual figures from 2021 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $1.2M | $135,000 | $0 | — | — |
| Gross profit | $1.2M | $135,000 | $0 | — | — |
| R&D expense | $7.5M | $9.1M | $6.0M | $2.5M | $2.8M |
| Operating income | -$12.2M | -$17.8M | -$14.2M | -$11.6M | -$4.4M |
| Interest expense | — | $244,000 | $1.1M | $630,000 | $212,000 |
| Income tax | $3,000 | $3,000 | $0 | $1,000 | -$1,000 |
| Net income | -$12.2M | -$24.8M | -$26.2M | -$12.2M | -$4.6M |
| EPS (diluted) | — | $-6.63 | $-30.26 | $-1.48 | $-0.63 |
| Operating cash flow | -$13.6M | -$16.0M | -$10.3M | -$7.8M | -$5.1M |
| Cash & equivalents | — | — | — | — | $51,567 |
| Inventory | $66,000 | $0 | — | — | — |
| Total assets | $14.2M | $4.7M | $3.5M | $3.0M | $603,000 |
| Total liabilities | $3.7M | $6.8M | $17.4M | $23.8M | $3.4M |
| Shareholders' equity | $10.4M | -$2.2M | -$13.9M | -$20.8M | -$2.8M |
Growth · year-over-year
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue growth | +814.1% | — | — | — | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.